skip to Main Content

Ella
Henry

Ella joined the Government Affairs team at Newmarket Strategy as a Consultant in May 2026. She brings experience working with pharmaceutical and MedTech organisations on policy, regulation and NHS decision-making. Her experience includes supporting engagement with Parliament and working with…

Read more

Charlie
Norell

Charlie brings over a decade of policy experience spanning HealthTech, biopharma, the NHS, and life sciences venture capital. He advises health and life sciences businesses and investors on policy, regulatory, and market access challenges, both in the UK and globally.…

Read more

Joe
Smale

Joe joined Newmarket Strategy in April 2026 as Consultant in the Strategic Government Affairs team. He brings five years' worth of experience in health and life sciences, working at both an industry trade association and a prominent patient organisation. During this time,…

Read more

Julie
Maniar

Julie brings extensive experience in risk management and finance and operational process transformation, with expertise spanning the full cycle, from sales and procurement through to cash management and financial reporting. Her career covers a diverse range of industries, and she…

Read more

Shaleena
Ravji

Shaleena is a Manager in Newmarket Strategy’s Service Strategy team, supporting clients across health systems, investor and commercial landscapes to unlock growth and strengthen market positioning. Her work spans market scoping, system and pathway design, partnership strategy and local market…

Read more

James
Lee

James, a senior value and access consultant, advises leading pharmaceutical companies across market access and commercial topics to help deliver new medicines to the NHS. He is supported by a background in strategy consulting across medical affairs, government affairs, and…

Read more

Meghan
McConville

Meghan McConville is a business development leader with over eight years’ experience in strategy and growth roles, with a focus on life sciences, healthcare and pharmaceuticals. She combines consulting experience at Putnam and PwC with hands-on advisory work as Founder and…

Read more

Robert
Kettell

Robert is one of the UK’s leading experts in pharmaceutical pricing and market access, having held senior positions within HM Treasury, the Department for Health and Social Care, and NHS England on life sciences policy and negotiation. Most recently, Robert…

Read more

Zuzanna
Opuchlik

Zuzanna has joined Newmarket Strategy as a Value & Access Consultant. She has previous experience working in an HEOR consultancy, where she supported HTA submissions and worked on the development of value communication tools, including economic models. Her experience spans…

Read more

Beth
Alderson

Beth previously worked at Asthma and Lung UK, where she helped to run the secretariat of the Taskforce for Lung Health and led on vaccines, specialised medicines, and community pharmacy policy. She also has a Master's in Global Politics from…

Read more
Back To Top